Company

Seelos Therapeutics, Inc.

Biotechnology 300 Park Avenue 7 employees CAPIT

Employees: 7
Contacts: 2
Emails: 2
Phones: 1

seelostherapeutics.com LinkedIn Crunchbase

Seelos Therapeutics, Inc. Overview

Headquarters: 300 Park Avenue
Website: seelostherapeutics.com
Industry: Biotechnology
Employees: 7
Founded: 2016
Stock Symbol: CAPIT
Funding: 1.1M
Company Email: Available in AeroLeads

Keywords

Rare Diseases Parkinson's Disease Sanfilippo Syndrome Suicidality Depression PTSD MDD CNS Disorders Pharmaceutical ALS

About Seelos Therapeutics, Inc.

Seelos Therapeutics, Inc. is a clinical-stage bio-pharmaceutical company focused on the development and advancement of novel therapeutics to address unmet medical needs for the benefit of patients with central nervous system (CNS) disorders and in rare diseases. The Company’s portfolio includes several late-stage clinical assets targeting psychiatric and movement disorders, including orphan diseases. Seelos is based in New York, New York. Seelos’ common stock is traded on The Nasdaq Capital Market under the symbol "SEEL".

Seelos Therapeutics, Inc. Contact Details

People in AeroLeads: 2
With contact data: 2
Email contacts: 2; 100.0% coverage
Phone contacts: 1; 50.0% coverage

Seelos Therapeutics, Inc. Org Chart

Sample employees and titles

Name	Title	Location	Contact
Gopal Krishna, Phd	Cmc Pharmaceutical Development and Technical/manufacturing Operations	Parsippany, New Jersey, United States	Email Phone
Krishna S.	Vice President - Non-clinical - Biotech - Translation - Cell and Gene Therapy - Pharmaceuticals - Public Speaker	Greater Boston, United States	Email